Interviews with Key Healthcare Opinion Leaders

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/02/f1/c2/02f1c26f-70d5-8475-c51f-55c728887ce4/mza_7175313792358046023.jpeg/600x600bb.jpg

Urban Health Weekly

119 episodes

4 months ago

The Urban Health Weekly Podcast: Medical News That Matters to You

Hosted on Acast. See acast.com/privacy for more information.

Medicine

Health & Fitness

RSS

All content for Urban Health Weekly is the property of Urban Health Weekly and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

The Urban Health Weekly Podcast: Medical News That Matters to You

Hosted on Acast. See acast.com/privacy for more information.

Medicine

Health & Fitness

https://assets.pippa.io/shows/6284520a3ad3490012e6b90d/1674774132427-9c04b20cd86b4ee97eb3c1a74147ec0c.jpeg

Interviews with Key Healthcare Opinion Leaders - Episode #103

Urban Health Weekly

43 minutes 35 seconds

6 months ago

Interviews with Key Healthcare Opinion Leaders - Episode #103

Dr. Andrew Hertler, Senior Advisor / Chief Medical Officer – emeritus for Evolent, explains ODAC’s September 2024 vote to support the FDA’s decision to restrict the use of PD-1 inhibitor drugs such as Opdivo, Keytruda, and Tevimbra for PD-L1-negative stomach cancer and esophageal cancer, and his support of using biomarkers to predict outcomes.

Hosted on Acast. See acast.com/privacy for more information.